Literature DB >> 25075381

Predicting mechanism of biphasic growth factor action on tumor growth using a multi-species model with feedback control.

Anna Konstorum1, Stephanie A Sprowl2, Marian L Waterman2, Arthur D Lander3, John S Lowengrub4.   

Abstract

A large number of growth factors and drugs are known to act in a biphasic manner: at lower concentrations they cause increased division of target cells, whereas at higher concentrations the mitogenic effect is inhibited. Often, the molecular details of the mitogenic effect of the growth factor are known, whereas the inhibitory effect is not. Hepatoctyte Growth Factor, HGF, has recently been recognized as a strong mitogen that is present in the microenvironment of solid tumors. Recent evidence suggests that HGF acts in a biphasic manner on tumor growth. We build a multi-species model of HGF action on tumor cells using different hypotheses for high dose-HGF activation of a growth inhibitor and show that the shape of the dose-response curve is directly related to the mechanism of inhibitor activation. We thus hypothesize that the shape of a dose-response curve is informative of the molecular action of the growth factor on the growth inhibitor.

Entities:  

Keywords:  Cancer Modeling; Cell Signaling; Coupled Dynamical Modeling; Nonlinear Biological Growth Control; Stem Cells

Year:  2013        PMID: 25075381      PMCID: PMC4112130          DOI: 10.1166/jcsmd.2013.1028

Source DB:  PubMed          Journal:  J Coupled Syst Multiscale Dyn


  38 in total

Review 1.  Wnt, stem cells and cancer in the intestine.

Authors:  Daniel Pinto; Hans Clevers
Journal:  Biol Cell       Date:  2005-03       Impact factor: 4.458

Review 2.  Towards an integrated view of Wnt signaling in development.

Authors:  Renée van Amerongen; Roel Nusse
Journal:  Development       Date:  2009-10       Impact factor: 6.868

Review 3.  Wnt signaling in stem and cancer stem cells.

Authors:  Jane D Holland; Alexandra Klaus; Alistair N Garratt; Walter Birchmeier
Journal:  Curr Opin Cell Biol       Date:  2013-01-21       Impact factor: 8.382

Review 4.  CD133 as a target for colon cancer.

Authors:  Veronica Catalano; Simone Di Franco; Flora Iovino; Francesco Dieli; Giorgio Stassi; Matilde Todaro
Journal:  Expert Opin Ther Targets       Date:  2012-03-03       Impact factor: 6.902

5.  A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway.

Authors:  Joon-Ho Cho; Manjari Dimri; Goberdhan P Dimri
Journal:  J Biol Chem       Date:  2012-12-13       Impact factor: 5.157

6.  Multispecies model of cell lineages and feedback control in solid tumors.

Authors:  H Youssefpour; X Li; A D Lander; J S Lowengrub
Journal:  J Theor Biol       Date:  2012-03-31       Impact factor: 2.691

Review 7.  TGF-β1 signalling, connecting aberrant inflammation and colorectal tumorigenesis.

Authors:  Victoria R Skeen; Ian Paterson; Christos Paraskeva; Ann C Williams
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 8.  TGF beta inhibition for cancer therapy.

Authors:  Elise F Saunier; Rosemary J Akhurst
Journal:  Curr Cancer Drug Targets       Date:  2006-11       Impact factor: 3.428

Review 9.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

10.  Cell lineages and the logic of proliferative control.

Authors:  Arthur D Lander; Kimberly K Gokoffski; Frederic Y M Wan; Qing Nie; Anne L Calof
Journal:  PLoS Biol       Date:  2009-01-20       Impact factor: 8.029

View more
  1 in total

1.  Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy.

Authors:  John A Kessler; A Gordon Smith; Bong-Soo Cha; Sung Hee Choi; James Wymer; Aziz Shaibani; Senda Ajroud-Driss; Aaron Vinik
Journal:  Ann Clin Transl Neurol       Date:  2015-03-05       Impact factor: 4.511

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.